"We're the biggest generic company in the world, and in the U.S., by far. But we have a large, branded business already, and with the Cephalon acquisition, we acquired a whole portfolio."
— Dr. Tushar Shah, a senior vice president for research and development at Teva Pharmaceuticals Ltd., on his company's 2011 purchase of Frazer-based Cephalon for $6.8 billion.
"We have to get into [patients'] brains, we have to get them engaged, to believe in themselves, to pick the right priorities on nutrition, on exercise. They are not a matter of technology, they are a matter of emotion."
— Independence Blue Cross president and chief executive Dan Hilferty, announcing that it will offer $50,000 plus mentoring from innovation experts for up to three "software applications, devices, products, education programs, or public awareness campaigns that can deliver a positive impact on our region's health, with special emphasis on driving healthy behaviors such as eating right and getting fit."
"We certainly haven't seen fees drop, and now we're starting to see some fees rise."
— Jean Ann Fox, director of financial services for the Consumer Federation of America, on banks increasing overdraft fees. "Consumers can be charged up to $370 in one day" under the fee rules set by the nation's 14 largest banks, Fox said.
"As always, the Federal Reserve remains prepared to take action as needed to protect the U.S. financial system and economy in the event that financial stresses escalate."
— Federal Reserve chairman Ben Bernanke, telling the congressional Joint Economic Committee of the central bank's vigilance in the shaky economy.
Compiled from The Inquirer, Associated Press and Bloomberg News.
